Hu E - Search Results

1

Identification of breast cancer risk modules via an integrated strategy.

Li W, Deng G, Zhang J, Hu E, He Y, Lv J, Sun X, Wang K, Chen L. Li W, et al. Among authors: hu e. Aging (Albany NY). 2019 Dec 20;11(24):12131-12146. doi: 10.18632/aging.102546. Epub 2019 Dec 20. Aging (Albany NY). 2019. PMID: 31860871 Free PMC article.

2

Identification of potential genes for human ischemic cardiomyopathy based on RNA-Seq data.

Li W, Li L, Zhang S, Zhang C, Huang H, Li Y, Hu E, Deng G, Guo S, Wang Y, Li W, Chen L. Li W, et al. Among authors: hu e. Oncotarget. 2016 Dec 13;7(50):82063-82073. doi: 10.18632/oncotarget.13331. Oncotarget. 2016. PMID: 27852050 Free PMC article.

3

Identification of breast cancer prognostic modules based on weighted protein-protein interaction networks.

Li W, Bai X, Hu E, Huang H, Li Y, He Y, Lv J, Chen L, He W. Li W, et al. Among authors: hu e. Oncol Lett. 2017 May;13(5):3935-3941. doi: 10.3892/ol.2017.5917. Epub 2017 Mar 27. Oncol Lett. 2017. PMID: 28529601 Free PMC article.

4

Association of PD-1 polymorphisms with the risk and prognosis of lung adenocarcinoma in the northeastern Chinese Han population.

Huang K, Hu E, Li W, Lv J, He Y, Deng G, Xiao J, Yang C, Zhao X, Chen L, Wang X. Huang K, et al. Among authors: hu e. BMC Med Genet. 2019 Nov 12;20(1):177. doi: 10.1186/s12881-019-0914-8. BMC Med Genet. 2019. PMID: 31718573 Free PMC article.

5

A susceptibility biomarker identification strategy based on significantly differentially expressed ceRNA triplets for ischemic cardiomyopathy.

Zou Y, Wang Y, Rong Z, Wei B, Liu Y, Song Z, Li W, Hu E, Deng G, He Y, Lv J, Chen L, Li W. Zou Y, et al. Among authors: hu e. Biosci Rep. 2020 Jan 31;40(1):BSR20191731. doi: 10.1042/BSR20191731. Biosci Rep. 2020. PMID: 31919492 Free PMC article.

6

Network-based integration method for potential breast cancer gene identification.

Zhang Y, Li W, Zhang Y, Hu E, Rong Z, Ge L, Deng G, He Y, Lv J, Chen L, He W. Zhang Y, et al. Among authors: hu e. J Cell Physiol. 2020 Nov;235(11):7960-7969. doi: 10.1002/jcp.29450. Epub 2020 Jan 14. J Cell Physiol. 2020. PMID: 31943201

7

Integration of SNP Disease Association, eQTL, and Enrichment Analyses to Identify Risk SNPs and Susceptibility Genes in Chronic Obstructive Pulmonary Disease.

Liu Y, Huang K, Wang Y, Hu E, Wei B, Song Z, Zou Y, Ge L, Chen L, Li W. Liu Y, et al. Among authors: hu e. Biomed Res Int. 2020 Dec 29;2020:3854196. doi: 10.1155/2020/3854196. eCollection 2020. Biomed Res Int. 2020. PMID: 33457407 Free PMC article.

8

Identification of Prognostic Stromal-Immune Score-Based Genes in Hepatocellular Carcinoma Microenvironment.

Liu S, Yu G, Liu L, Zou X, Zhou L, Hu E, Song Y. Liu S, et al. Among authors: hu e. Front Genet. 2021 Feb 11;12:625236. doi: 10.3389/fgene.2021.625236. eCollection 2021. Front Genet. 2021. PMID: 33643387 Free PMC article.

9

ggtreeExtra: Compact Visualization of Richly Annotated Phylogenetic Data.

Xu S, Dai Z, Guo P, Fu X, Liu S, Zhou L, Tang W, Feng T, Chen M, Zhan L, Wu T, Hu E, Jiang Y, Bo X, Yu G. Xu S, et al. Among authors: hu e. Mol Biol Evol. 2021 Aug 23;38(9):4039-4042. doi: 10.1093/molbev/msab166. Mol Biol Evol. 2021. PMID: 34097064 Free PMC article.

10

Stemness Analysis Uncovers That The Peroxisome Proliferator-Activated Receptor Signaling Pathway Can Mediate Fatty Acid Homeostasis In Sorafenib-Resistant Hepatocellular Carcinoma Cells.

Feng T, Wu T, Zhang Y, Zhou L, Liu S, Li L, Li M, Hu E, Wang Q, Fu X, Zhan L, Xie Z, Xie W, Huang X, Shang X, Yu G. Feng T, et al. Among authors: hu e. Front Oncol. 2022 Jul 22;12:912694. doi: 10.3389/fonc.2022.912694. eCollection 2022. Front Oncol. 2022. PMID: 35957896 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

811 results

Search Page